cyclosporine has been researched along with Atherogenesis in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (43.75) | 29.6817 |
| 2010's | 8 (50.00) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Asci, G; Celtik, A; Goktepe, B; Kivratma, G; Sezer, TO; Toz, H | 1 |
| Carsons, SE; DeLeon, J; Kasselman, LJ; Mattana, J; Miyawaki, N; Reiss, AB; Salama, M; Teboul, I; Voloshyna, I | 1 |
| Akashi, K; Horiuchi, T; Kiyohara, C; Niiro, H; Oryoji, K; Shimoda, T; Tsukamoto, H; Yanase, T | 1 |
| Bu, H; Li, H; Wang, W; Wu, HK; Zhang, P | 1 |
| Chhatrala, R; Driscoll, C; Luketic, V; Matherly, S; Puri, P; Sanyal, A; Sargeant, C; Sharma, A; Siddiqui, MB; Siddiqui, MS; Sterling, R; Stravitz, RT | 1 |
| Bachta, A; Bogusławska-Walecka, R; Duda, K; Juszkiewicz, A; Kisiel, B; Kruszewski, R; Kłos, K; Płoski, R; Raczkiewicz, A; Staniszewska-Varga, J; Tłustochowicz, M; Tłustochowicz, W | 1 |
| Hirsch, GM; Lee, TD; Zaki, AM | 1 |
| Bigalke, B; Borst, O; Daub, K; Gawaz, M; Heidenreich, O; Herouy, Y; Krämer, BF; Lang, MR; Langer, HF; Lindemann, S; May, AE; Schmidt, R; Schönberger, T; Schött, M; Seizer, P | 1 |
| Jessup, W; Kockx, M; Kritharides, L | 1 |
| Haron, MM; Houssen, ME; Ibrahim, TM; Metwally, SS | 1 |
| Moghadasian, MH | 1 |
| Carl, SM; Friedman, GS; Jin, S; Knipp, GT; Mathis, AS; Peng, F | 1 |
| Czubkowski, P; Ismail, H; Jankowska, I; Pawłowska, J; Skorupa, E; Socha, J; Socha, P; Teisseyre, M; Wierzbicka, A | 1 |
| Cavelier, C; Lorenzi, I; Radosavljevic, S; Rohrer, L; von Eckardstein, A | 1 |
| Alonso, A; Arias, M; González Molina, M; Sánchez-Plumed, JA | 1 |
| Lorkowski, S | 1 |
2 review(s) available for cyclosporine and Atherogenesis
| Article | Year |
|---|---|
Cyclosporin A and atherosclerosis--cellular pathways in atherogenesis.
Topics: Animals; Atherosclerosis; Cardiovascular Diseases; Cyclosporine; Humans; Immunosuppressive Agents; NFATC Transcription Factors; Signal Transduction | 2010 |
Sirolimus, the first mTOR inhibitor.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Atherosclerosis; Bone Marrow Diseases; Cell Division; Clinical Trials as Topic; Cyclosporine; Graft Rejection; Graft vs Host Disease; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Lymphocyte Subsets; Mice; Multicenter Studies as Topic; Muscle, Smooth, Vascular; Neoplasms; Postoperative Complications; Sirolimus; TOR Serine-Threonine Kinases; Wound Healing | 2006 |
14 other study(ies) available for cyclosporine and Atherogenesis
| Article | Year |
|---|---|
Is Serum Magnesium Level Associated With Serum Lipid Levels in Kidney Transplant Recipients?
Topics: Adolescent; Aged; Atherosclerosis; Cholesterol, LDL; Cross-Sectional Studies; Cyclosporine; Humans; Hyperlipidemias; Kidney Transplantation; Lipoproteins, HDL; Magnesium; Retrospective Studies; Tacrolimus; Triglycerides | 2023 |
Macrophage lipid accumulation in the presence of immunosuppressive drugs mycophenolate mofetil and cyclosporin A.
Topics: Animals; Atherosclerosis; Bone Marrow Cells; Cell Differentiation; Cholesterol; Cyclosporine; Foam Cells; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Lipid Metabolism; Macrophages; Mice; Monocytes; Mycophenolic Acid; THP-1 Cells | 2019 |
Reduced carotid intima-media thickness in systemic lupus erythematosus patients treated with cyclosporine A.
Topics: Adult; Atherosclerosis; Carotid Arteries; Carotid Artery Diseases; Carotid Intima-Media Thickness; Cyclosporine; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Middle Aged; Risk Factors | 2014 |
[The mechanism of ciclosporin A regulating the expression of LOX-1 on vascular endothelium of hyperlipidemic rats].
Topics: Animals; Atherosclerosis; C-Reactive Protein; Cyclosporine; Endothelial Cells; Endothelium, Vascular; Hyperlipidemias; Rats; Reactive Oxygen Species; Scavenger Receptors, Class E; Up-Regulation | 2014 |
Evolution of serum atherogenic risk in liver transplant recipients: Role of lipoproteins and metabolic and inflammatory markers.
Topics: Aged; Atherosclerosis; Biomarkers; Body Mass Index; Cholesterol, HDL; Cholesterol, LDL; Cross-Sectional Studies; Cyclosporine; Female; Humans; Immunosuppression Therapy; Inflammation; Lipoproteins; Liver Cirrhosis; Liver Failure; Liver Transplantation; Male; Middle Aged; Prospective Studies; Risk; Tacrolimus; Transplant Recipients | 2015 |
Methotrexate, Cyclosporine A, and Biologics Protect against Atherosclerosis in Rheumatoid Arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Atherosclerosis; Biological Products; Carotid Intima-Media Thickness; Case-Control Studies; Cyclosporine; Disease Progression; Female; Humans; Male; Methotrexate; Middle Aged; Prevalence; Severity of Illness Index | 2015 |
Contribution of pre-existing vascular disease to allograft vasculopathy in a murine model.
Topics: Animals; Aorta; Apolipoproteins E; Atherosclerosis; CD4-Positive T-Lymphocytes; Cyclosporine; Disease Models, Animal; Foam Cells; Graft Rejection; Green Fluorescent Proteins; Macrophages; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Tissue Donors; Transplantation, Homologous; Tunica Intima; Tunica Media; Vascular Diseases | 2009 |
EMMPRIN and its ligand cyclophilin A regulate MT1-MMP, MMP-9 and M-CSF during foam cell formation.
Topics: Animals; Antigens, CD34; Apolipoproteins E; Atherosclerosis; Basigin; Cell Differentiation; Cell Movement; Collagen; Cyclophilin A; Cyclosporine; Drug Combinations; Foam Cells; Humans; Laminin; Ligands; Macrophage Colony-Stimulating Factor; Macrophages; Matrix Metalloproteinase 14; Matrix Metalloproteinase 9; Mice; Mice, Mutant Strains; Proteoglycans; Stem Cells | 2010 |
Effects of immunomodulatory drugs on plasma inflammatory markers in a rabbit model of atherosclerosis.
Topics: Animals; Atherosclerosis; Atorvastatin; Biomarkers; C-Reactive Protein; Cholesterol; Cholesterol, Dietary; Cholesterol, HDL; Cholesterol, LDL; Cyclosporine; Heptanoic Acids; Immunologic Factors; Inflammation; Interferon-gamma; Interleukin-6; Male; Plasma; Pyrroles; Rabbits; Tacrolimus; Triglycerides | 2011 |
Dietary phytosterols reduce cyclosporine-induced hypercholesterolemia in apolipoprotein E-knockout mice.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Body Weight; Cyclosporine; Diet; Humans; Hypercholesterolemia; Immunosuppressive Agents; Lipids; Male; Mice; Mice, Knockout; Phytosterols; Transplants | 2006 |
The pharmacodynamic effects of sirolimus and sirolimus-calcineurin inhibitor combinations on macrophage scavenger and nuclear hormone receptors.
Topics: Atherosclerosis; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; Calcineurin Inhibitors; CD36 Antigens; Cell Line; Cyclosporine; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Interactions; Gene Expression Regulation; Humans; Immunosuppressive Agents; Liver X Receptors; Macrophages; Orphan Nuclear Receptors; PPAR gamma; Receptors, Cytoplasmic and Nuclear; Receptors, Scavenger; RNA, Messenger; Sirolimus; Tacrolimus; Time Factors | 2007 |
Lipid, carbohydrate metabolism, and antioxidant status in children after liver transplantation.
Topics: Antioxidants; Atherosclerosis; Child; Child, Preschool; Cyclosporine; Dietary Carbohydrates; Dietary Fats; Drug Therapy, Combination; Follow-Up Studies; Glutathione; Glutathione Peroxidase; Humans; Immunosuppressive Agents; Lipoproteins; Liver Transplantation; Postoperative Complications; Retrospective Studies; Tacrolimus; Time Factors | 2007 |
Apolipoprotein A-I but not high-density lipoproteins are internalised by RAW macrophages: roles of ATP-binding cassette transporter A1 and scavenger receptor BI.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Apolipoprotein A-I; Atherosclerosis; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; Cell Line; Cell Membrane; Cholesterol; Cyclic AMP; Cyclosporine; Endocytosis; Foam Cells; Lipoproteins, HDL; Lipoproteins, LDL; Macrophages; Mice; RNA Interference; RNA, Small Interfering; Scavenger Receptors, Class B; Transfection | 2008 |
The ins and outs of lipid efflux.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Apolipoprotein A-I; Atherosclerosis; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; Cell Membrane; Cholesterol; Cyclic AMP; Cyclosporine; Endocytosis; Foam Cells; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Macrophages; Mice; RNA Interference; RNA, Small Interfering; Scavenger Receptors, Class B | 2008 |